A detailed history of Badgley Phelps Wealth Managers, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Badgley Phelps Wealth Managers, LLC holds 23,222 shares of BMY stock, worth $1.31 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
23,222
Previous 23,865 2.69%
Holding current value
$1.31 Million
Previous $991,000 21.19%
% of portfolio
0.03%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$39.66 - $51.75 $25,501 - $33,275
-643 Reduced 2.69%
23,222 $1.2 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $68,425 - $90,083
-1,700 Reduced 6.65%
23,865 $991,000
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $209,480 - $237,510
-4,366 Reduced 14.59%
25,565 $1.39 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $12.2 Million - $14.5 Million
-250,919 Reduced 89.34%
29,931 $1.54 Million
Q3 2023

Nov 02, 2023

BUY
$57.89 - $64.73 $111,322 - $124,475
1,923 Added 0.69%
280,850 $16.3 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $529,939 - $588,415
8,318 Added 3.07%
278,927 $17.8 Million
Q1 2023

Apr 28, 2023

BUY
$65.71 - $74.53 $370,144 - $419,827
5,633 Added 2.13%
270,609 $18.8 Million
Q4 2022

Jan 27, 2023

BUY
$68.48 - $81.09 $367,463 - $435,128
5,366 Added 2.07%
264,976 $0
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $409 - $241,892
3,148 Added 1.23%
259,610 $18.5 Million
Q2 2022

Aug 01, 2022

SELL
$72.62 - $79.98 $6,608 - $7,278
-91 Reduced 0.04%
256,462 $19.7 Million
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $15.3 Million - $18.4 Million
249,611 Added 3595.66%
256,553 $18.7 Million
Q4 2021

Feb 08, 2022

SELL
$53.63 - $62.52 $11,691 - $13,629
-218 Reduced 3.04%
6,942 $433,000
Q3 2021

Nov 29, 2021

BUY
$59.17 - $69.31 $423,657 - $496,259
7,160 New
7,160 $424,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Badgley Phelps Wealth Managers, LLC Portfolio

Follow Badgley Phelps Wealth Managers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Badgley Phelps Wealth Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Badgley Phelps Wealth Managers, LLC with notifications on news.